logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Samuel J Rose

This inventor holds 24 USPTO granted patents, primarily in Nucleic Acid Amplification. Top assignees: Behringwerke Aktiengesellschaft, Syntex (u.s.a.) Inc., Dade Behring Marburg Gmbh. Active years: 1991-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel J Rose. Retrieved from https://idiyas.com/inventor/samuel-j-rose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 95.8

Average Co-Inventor Count = 2.6

ph-index = 17

Forward Citations = 1,529(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1996)
  • Mountain View, CA (US) (1991 - 2001)
  • Los Altos, CA (US) (1997 - 2002)
  • Oakland, CA (US) (1998 - 2002)
  • Emeryville, CA (US) (2010)

Company Filing History:

goldMedal6 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
silverMedal5 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal4 out of 149 
 
Dade Behring Marburg Gmbh
 patents
4. 2 out of 113 
 
Dade Behring Inc.
 patents
5. 1 out of 39 
 
Behring Diagnostics Gmbh
 patents
6. 1 out of 2 
 
Oncologic, Inc.
 patents
7. 1 out of 47 
 
Syntex LLC
 patents
8. 4 out of 834,659 
Other
 patents

Years Active: 1991-2010

Loading Chart...
Areas of Expertise:
Nucleic Acid
Amplification
Cancer Treatment
Enzymatic Conversion
Detection
Oligonucleotides
Single Primer
Nucleotide Probes
Polynucleotide
Homogeneous Amplification
Target-Catalyzed
Internal Controls
24 patents (USPTO):Explore Patents
1. 7807136 - Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer (2010-10-05),
2. 6468503 - Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer (2002-10-22),
3. 6368803 - Detection of nucleic acids by target-catalyzed formation (2002-04-09),
4. 6294323 - Self initiating single primer amplification of nucleic acids (2001-09-25),
5. 6124090 - Nucleic acid amplification using single primer (2000-09-26),
6. 6121001 - Detection of nucleic acids by target-catalyzed product formation (2000-09-19),
7. 6110677 - Oligonucleotide modification, signal amplification, and nucleic acid (2000-08-29),
8. 6080383 - Method and composition for the treatment of cancer by the enzymatic (2000-06-27),
9. 5914230 - Homogeneous amplification and detection of nucleic acids (1999-06-22),
10. 5882867 - Detection of nucleic acids by formation of template-dependent product (1999-03-16),
11. 5882857 - Internal positive controls for nucleic acid amplification (1999-03-16),
12. 5827649 - Kits for nucleic acid amplification kit using single primer (1998-10-27),
13. 5816259 - Method for the diagnosis and treatment of cancer by the accumulation of (1998-10-06),
14. 5792614 - Detection of nucleic acids by target-catalyzed product formation (1998-08-11),
15. 5750343 - Methods of detecting nucleic acids with nucleotide probes containing (1998-05-12),

Title: The Inventor Samuel J Rose: Pioneering Innovations in Los Altos

Introduction: Samuel J Rose is a distinguished inventor based in Los Altos, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Samuel J Rose holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Samuel J Rose has worked with renowned companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Samuel J Rose has collaborated with leading researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects.

Conclusion: Samuel J Rose's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…